Caris Life Sciences vs PFx Biotech
Caris Life Sciences vs PFx Biotech, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Caris Life Sciences is on 59/100 and PFx Biotech on 51/100.
Where each one leads
Caris Life Sciences
- our overall score: 59/100 against 51/100
- domain rating: 63/100 against 17/100
- headcount: 1,659 against 9
- funding raised: $700M against $5.2M
- LinkedIn following: 77,698 against 3,138
PFx Biotech
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Caris Life Sciences | PFx Biotech |
|---|---|---|
| What it is | Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling. | PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, Drug Discovery, Genomics, AI-Driven Protein Design |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2008 | 2017 |
| Headquarters | Irving, United States | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Caris Life Sciences | PFx Biotech |
|---|---|---|
| Employees | 1,659 | 9 |
| Total funding | $700M | $5.2M |
| Latest round | Series D | Not published |
| Valuation | $7.8B | Not published |
| LinkedIn followers | 77,698 | 3,138 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Caris Life Sciences | PFx Biotech |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 51/100 |
| Traction | 60/100 | 44/100 |
| Team | Not published | 60/100 |
| Search visibility | 22/100 | 29/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (47/100) | D (44/100) |
| Domain ratingLink authority, 0-100 | 63/100 | 17/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Caris Life Sciences | PFx Biotech |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | Not detected |
| Analytics | Google Tag Manager | Not detected |
| Open source | No | Yes |
Caris Life Sciences vs PFx Biotech: common questions
Which is better, Caris Life Sciences or PFx Biotech?
On our 0-100 score Caris Life Sciences rates higher (59/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Caris Life Sciences and PFx Biotech compare on the numbers?
Caris Life Sciences leads on our overall score (59/100 against 51/100), domain rating (63/100 against 17/100), headcount (1,659 against 9), funding raised ($700M against $5.2M), LinkedIn following (77,698 against 3,138).
Read the full Caris Life Sciences review and pricing or the PFx Biotech review and pricing. You can also browse other Caris Life Sciences alternatives we track.